DGCI approves emergency use of Zydus Cadila’s Virafin for COVID-19

On Friday 23 April Drugs Controller General of India  (DGCI) approved the emergency use for Zydus Cadila’s Pegylated Interferon alpha-2b, ‘Virafin’ for treating moderate COVID-19 infection in adults. According to Cadila Health, one dose of Pegylated Interferon Alpha-2b, ‘Virafin’ showed clinical and virological improvement in moderate COVID-19 cases. The Ahmedabad-based […]